December 2, 2025 · Form 4 insider transaction
Borgeson Blake sold 220,000 shares of Recursion Pharmaceuticals Inc at $4.37 per share, a transaction worth $961.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.